— Research & Development
Oncology Pipeline
We continue to build our treatment portfolio with a current focus on oncology within the United States.
Learn More— Join Our Team
See a Future at Servier?
Learn more about working at Servier and search our current job openings to see if there is a career opportunity for you.
Learn More
Latest News

During #NationalCancerControlMonth, we recognize that while progress has been made in the fight against cancer, much work remains. At Servier, we are committed to preventing cancer and improving treatment options for patients.
Learn More
Today, our Global Head of M&A and Venture Investments joins @ldtimmerman alongside a team of oncology patients, survivors and industry leaders to advance cancer research in the hike to Everest Base Camp!
Learn More
Servier Announces FDA Filing Acceptance and Priority Review for TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine for Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia
Learn MoreAdobe Stock©Mat Hayward | Adobe Stock©REDPIXEL | Adobe Stock©Gorodenkoff | Adobe Stock©Monkey Business